DNMT3A mutations, an independent risk factor for arterial thrombosis in MPN, leads to aggressive inflammatory transcriptome, enhance macrophage activity and stimulate proinflammatory T-cell polarization [25]. This evidence concerns the gene DNMT3A and myeloproliferative neoplasm.